GOTHENBURG, Sweden, Dec. 8, 2025 /PRNewswire/ -- Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that the U.S. Food and Drug Administration...
Hence then, the article about cereno scientific receives fda clearance to initiate global phase iib trial of cs1 in pulmonary arterial hypertension pah was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH) )
Also on site :
- Monroe County committees vote to accept $160,000 Operation Stonegarden border security grant despite opposition
- 1985 Hit Novel, Written By a 21-Year-Old, Was Inspired By an Elvis Costello Song
- Beloved Romance Author Wants to Turn Jen Hamilton's Divorce Into Her Nex Best Seller — Under One Condition